The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention

Back

ESC Professional Premium Access

The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention

Session: Risk stratification in percutaneous coronary intervention (1)

Topic: Prevention

Speaker: Doctor K. Mahmoud (Cairo, EG)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Kareem Mahmoud

Cairo university, Cairo (Egypt)

0 follower

8 more presentations in this session

A new hydration strategy can reduce contrast-induced acute kidney injury after PCI in patients with chronic heart failure and chronic kidney disease: a two-center randomized controlled trial

Speaker: Professor K. Chen (Tianjin, CN)

Prognostic outcome of ACS in HTX patients after PCI

Speaker: Ms L. Elbinger (Bad Oeynhausen, DE)

Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention

Speaker: Doctor A. Oliva (New York, US)

Gender differences in coronary artery disease patterns

Speaker: Doctor D. Munhoz (Aalst, BE)

Impact of neutrophil-to-lymphocyte ratio on clinical outcomes in patients with or without chronic kidney disease undergoing percutaneous coronary intervention

Speaker: Doctor A. Oliva (New York, US)

Access the full session

Risk stratification in percutaneous coronary intervention (1)

Speakers: Doctor K. Mahmoud, Professor K. Chen, Ms L. Elbinger, Doctor A. Oliva, Doctor D. Munhoz...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources